Cost Analysis Of Treatment Success To Achieve A Clinically Relevant Composite Endpoint For Patients With Type-2 Diabetes On Liraglutide Or Other Antidiabetic Therapies In A Chinese Setting
May 1, 2013, 00:00
10.1016/j.jval.2013.03.802
https://www.valueinhealthjournal.com/article/S1098-3015(13)00873-5/fulltext
Title :
Cost Analysis Of Treatment Success To Achieve A Clinically Relevant Composite Endpoint For Patients With Type-2 Diabetes On Liraglutide Or Other Antidiabetic Therapies In A Chinese Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00873-5&doi=10.1016/j.jval.2013.03.802
First page :
A160
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
345